Assistant Professor Lena Smirnova

Neural organoid microphysiological systems inc Ai and new methodologies for developmental neurotoxicity testing and understanding gene environmental interactions in autism. Johns Hopkins Bloomberg School of Public Health, USA.

Professor Luc van der Laan.  Macrophage-augmented organoids recapitulate the complex pathophysiology of viral diseases and enable development of multitarget therapeutics

Dr Helena Rannikmae

Advancing translational in vitro models, including organoids, microphysiological systems and 3D bioprinted constructs to support different therapeutic areas.

Complex In Vitro Models, GSK. UK

Dr. Benjamin P. Sharpe  

Patient-derived tumour assembloid models for modelling the tumour microenvironment of esophageal cancer

Southampton University. U.K

Dr Miina Bjorninen. 

3D muscle-on-a-chip solutions and bioprinting vascularised bone. 

Centre of Excellence in Body-on-Chip Research. Tampere University, Finland

Jun Professor Hannes Beyer. Programmable synthetic 3-D tissue culture models with intrinsic sense- and response-behavior, and optogenetic (light-responsive) control.  

University of Düsseldorf. Germany.

Dr Julia Hesse.

The development and application of human pathological Vasculature 3D models.

University of Düsseldorf. Germany.

Professor Lyle Armstrong. Developing organoid and other complex models of human tissues for advancing pre-clinical science in both drug discovery and toxicology.

Stem Cell Sciences, Newcastle University and CSO Newcells Biotech. U.K

Dr Adriana Buskin. 

'Modelling Prostate Cancer and Therapy Resistance Using iPSC-Derived Organoids'

Translational and Clinical Research Institute, Newcastle University Centre for Cancer. U.K

Organ-on-chip technology to study cardiovascular, renal and metabolic diseases and to advance the development of future treatments. AstraZeneca, Sweden.

Professor Johanna Bolander  

Compartmentalized models, including: Pain on a chip, Osteoarthritis on a chip & Neurovasculature on a chip

Julius Wolff Institut (JWI) - Center for Musculoskeletal Biomechanics and Regeneration. Germany. 

Professor Hanne Scholz. Tools for cell-based therapies to treat diabetes in a pre-clinical and clinical setting including a pump-Less, Recirculating Organ-on-Chip (rOoC) Platform to Model the Metabolic Crosstalk between Islets and Liver

Department of Transplantation Medicine, Oslo University Hospital, University Of Oslo. Norway.

Professor Ozlem Yesil Celiktas. Multidisciplinary approaches to design and develop organ-on-chip platforms including

Professor Elzbieta Jastrzebska. 

Organ-on-a-Chip systems for cardiac organoids engineering.

Warsaw University of Technology, Poland.

Professor Rick Livesey. Novel human stem cell models of Alzheimer’s disease provide a transformative platform for rapid and more therapeutically relevant compound identification.

CEO, Talisman Therapeutics, U.K

Dr Magdalena Kasendra

Autologous Organoid-T Cell Co-Culture Platform for Modeling of Immune-Mediated Drug-Induced Liver Injury

Center for Stem Cell and Organoid Medicine, Cincinnati Children's Hospital Medical Center. USA

Dr Nicole Prior

Liver development and regeneration using 3D organoid systems 

Southampton University, U.K.

Professor Giovanni Tonon.  

3D organoids drug screening advances for Functional Genomics in Oncology.

San Raffaele Scientific Institute in Milan, Italy 

Dr Petra de Graaf . Organoids and organ on a chip studies of the urogenital tract including a novel vascularized urethra-on-a-chip model a platform to study the pathogenesis of urethral diseases and verify the effectiveness of drug treatment.

UMC Utrecht. Netherlands.

Dr. Pablo F. Céspedes. Lymphoid organoid and explant hub, CAMS. Discovery framework technologies including synthetic antigen-presenting cells (sAPC) and lymphoid organoids supporting the dissection of T cell communication. 

University of Oxford. U.K

Dr. Louis-Bastien Weiswald. 

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.

Also update on head and neck cancer organoid research. 

Comprehensive Cancer Center François Baclesse, France